抗增殖和试酸性活动的伊弗梅克生物结合物
Michał Sulik1, Dagmara Otto-Ślusarczyk2, Dietmar Steverding3
1Department of Medical Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznańskiego 8, 61-614 Poznań, Poland.
ACS omega
|July 7, 2025
概括
这项研究合成了新的Ivermectin (IVR) 生物结合物,用于对抗癌症和寄生虫疾病. 一个IVR-artesunate混合体显示出强大的抗癌活性,没有毒性,表明治疗潜力.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 寄生虫学的寄生虫学
背景情况:
- 伊弗梅克丁 (IVR) 是诺贝尔奖获得者的一种抗寄生虫药物,具有新兴的抗癌潜力.
- 关于IVR衍生物用于癌症治疗的研究有限.
- 耐药性需要针对寄生虫疾病的新型治疗策略.
研究的目的:
- 合成新型的艾弗梅克丁生物结合物.
- 评估它们的抗癌和抗微生物活性.
- 评估对非洲试索米亚症和癌症细胞系的疗效.
主要方法:
- 合成了十种新的IVR生物结合物.
- 合成化合物的生物评估.
- 细胞毒性和选择性指数的评估.
主要成果:
- 与原始化合物相比,一些合成的合物显示出增强的生物活性.
- 对于许多杂交动物来说,观察到选择性指数的增加.
- IVR-artesunate结合物 (化合物16) 显示出显著的功效,对参考细胞系没有毒性.
结论:
- 新的IVR生物结合物为癌症和寄生虫感染提供了有前途的治疗潜力.
- IVR-artesunate结合物表现出卓越的疗效和安全性,需要进一步研究.
- 这项工作扩大了IVR衍生物在药物发现中的范围.
更多相关视频
14:26Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns
Published on: April 6, 2019
10.3K
08:48In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
3.4K
相关概念视频
Inhibitors of Viral Protein Synthesis
73
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Antifungal Agents
131
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
131
Anthelminthic Agents
115
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
115
